Skip to content

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02431377
Enrollment
40
Registered
2015-05-01
Start date
2015-04-30
Completion date
2015-10-31
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Formula Intolerance

Keywords

infant formula

Brief summary

A single center, non-controlled trial to document the gastrointestinal (GI) tolerability of the study formula (SF), containing a whey protein concentrate enriched with alpha-lactalbumin (WPC alpha-lac) fed for 6 weeks to healthy, term infants.

Detailed description

The purpose of this study is to examine the tolerable and acceptability of an infant formula with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance, and eating behaviors.

Interventions

A commercial whey protein dominant, first age formula, containing whey protein concentrate with alpha-lactalbumin

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Days to 35 Days
Healthy volunteers
Yes

Inclusion criteria

1. Written informed consent 2. Healthy, full term, singleton infant 3. Be between 28±7 days post-natal age 4. Infants at enrollment, weight-for-age ≥ 5th and ≤ 95th percentile according to World Health Organization growth tables / charts 5. Infants must be exclusively consuming and tolerating a cow's milk infant formula for a minimum of 3 consecutive days and parent(s)/LAR must have previously made the decision to continue to exclusively formula feed 6. Have sufficient command of Tagalog or English language to complete the informed consent and other study documents 7. Are willing and able to fulfill the requirements of the study protocol 8. Have reached the legal age of consent in the Philippines 9. Able to be contacted by telephone throughout the study

Exclusion criteria

1. Infants who are receiving any amount of supplemental human milk 2. Family history of siblings with documented cow's milk protein intolerance/allergy 3. Conditions requiring infant feedings other than those specified in the protocol

Design outcomes

Primary

MeasureTime frame
Infant Gastrointestinal Symptom Questionnaire Composite Index Score6 weeks

Secondary

MeasureTime frame
Formula Intake volume6 weeks
Stool Consistency Score6 weeks
Baby Eating Behaviour Questionnaire Profile6 weeks
Infant Characteristics Questionnaire (ICQ) Profile6 weeks
Infant Toddler Quality of Life Profile6 weeks

Other

MeasureTime frame
Clinician-reported GI Adverse Event Profile6 weeks

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026